… breast cancer—a subtype affecting about 70% of breast cancer … most aggressive forms of breast cancer, offering patients longer … combined with the hormone therapy fulvestrant—was found to … breast cancer—a subtype affecting about 70% of breast cancer patients …

… treatments like radiation and hormone therapy following surgery. These … their risk of invasive breast cancer," says Northwestern … surgeon Swati Kulkarni. Breast cancer cells highlighted in green … risk of developing breast cancer, and provide supportive …

… , breast cancer is … breast cancer (ER+ or PR+), HER2-positive breast cancer (HER2+), and triple-negative breast cancer … hormone therapy, radiotherapy, chemotherapy, and immunotherapy.4 However, the heterogeneity of the breast cancer … within breast tumor tissues, …

… creams by postmenopausal breast cancer survivors was … . However, many breast cancer survivors avoid these products … significant increase in breast cancer-specific survival, … hormone therapy is not associated with increased risk to overall or breast cancer …

… creams by postmenopausal breast cancer survivors was … during intercourse, but breast cancer survivors often avoid … significant increase in breast cancer-specific survival – … hormone therapy is not associated with increased risk to overall or breast cancer …

… positive, HER2-negative early breast cancer, Kisqali (ribociclib) plus … during which no invasive breast cancer returns or spreads. … (NSAI): type of hormone therapy that lowers estrogen levels … stop hormone receptor–positive breast cancer. ECOG performance status …

… positive, HER2-negative advanced breast cancer, according to research  … advanced HR-positive breast cancer, a number of … -negative advanced breast cancer often receive hormone therapy—most commonly an … -sensitive HR-positive breast cancer develop ESR1 mutations …

… common occurrence in patients with breast cancer (BC) being treated with novel … concern, particularly for patients on hormone therapies such as endocrine therapies, which … effects of new and emerging breast cancer therapies. 2025 ASCO Annual Meeting …

… . It can be used by breast cancer survivors as it does not … same risks associated with menopause hormone therapy (MHT).  Non-antibiotic prevention - …

… menopause symptoms could double as breast cancer prevention. New research from … menopause symptoms could double as breast cancer prevention, new research suggests. … are typically advised against standard hormone therapies, leaving them with few menopausal …